PATH
Menu

This fact sheet highlights PATH's work to develop a vaccine against respiratory syncytial virus (RSV) for use in a maternal immunization strategy in the developing world that can protect infants in the critical early months of life.

Corporate author(s): PATH

Publication date: September 2013

Available materials

English

Paving the Way for Respiratory Syncytial Virus Prevention

93 KB PDF

Hard copies are not available.

Some digital files may be saved at low resolutions to conserve file size. Versions with higher quality may be available; see the contact information below to enquire.

Region: Global

See also:

About PATH's workAdvancing technologies

For advocates and policymakersChild health

Health technologiesNewborn health

Vaccines and immunizationMiscellaneous

For more information…

Contact: PATH Publications
Email: publications@path.org
Mailing address: PATH, PO Box 900922, Seattle, WA 98109 USA